Library

Home > Library

Search results : competition

Bidenomics 2.0: trade, taxation, and technology

2024-02-14This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 4 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Bidenomics

2022-09-21This ebook delves into key financial topics and stock market investment articles.

This AYA analytic ebook delves into the macroeconomic and technological aspects of Bidenomics from mid-2020 to present. This ebook comprises 3 main parts. The first part explains the pre-Biden Trump economic policy reforms in t...+See More
Key motifs in the merry medley of Trump economic reform 2016-2020

2020-06-06This ebook delves into key financial topics and stock investment memes blog posts and essays.

This ebook offers the key motifs in the merry medley of Trump economic reform 2016-2020: (1) Federal Reserve monetary policy decisions and interest rate adjustments in response to inflationary fluctuations, economic output g...+See More
1

Blog+More

CNBC All-America Economic Survey indicates 54% majority approval of the Trump team's supply-side economic reform.

Jonah Whanau

2018-07-11 09:39:00 Wednesday ET

CNBC All-America Economic Survey indicates 54% majority approval of the Trump team's supply-side economic reform.

In recent times, the Trump administration sees the sweet state of U.S. economic expansion as of early-July 2018. The latest CNBC All-America Economic Survey

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

Anti-competitive corporate practices may stifle U.S. innovation.

Fiona Sydney

2020-01-15 08:31:00 Wednesday ET

Anti-competitive corporate practices may stifle U.S. innovation.

Anti-competitive corporate practices may stifle U.S. innovation. In recent decades, wage growth, economic output, and productivity tend to stagnate as U.S.

+See More

The Sino-American trade war may slash global GDP by $600 billion.

Monica McNeil

2019-06-15 10:28:00 Saturday ET

The Sino-American trade war may slash global GDP by $600 billion.

The Sino-American trade war may slash global GDP by $600 billion. If the Trump administration imposes tariffs on all the Chinese imports and China retaliate

+See More

Nobel Laureate Paul Milgrom explains the U.S. incentive auction of wireless spectrum allocation from TV broadcasters to telecoms.

Rose Prince

2023-11-21 11:32:00 Tuesday ET

Nobel Laureate Paul Milgrom explains the U.S. incentive auction of wireless spectrum allocation from TV broadcasters to telecoms.

Nobel Laureate Paul Milgrom explains the U.S. incentive auction of wireless spectrum allocation from TV broadcasters to telecoms. Paul Milgrom (2019)

+See More

Response to USPTO fintech patent protection and accreditation

Andy Yeh Alpha

2023-01-09 10:31:00 Monday ET

Response to USPTO fintech patent protection and accreditation

Response to USPTO fintech patent protection As of early-January 2023, the U.S. Patent and Trademark Office (USPTO) has approved our U.S. utility patent

+See More